Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

GTX Inc (NASDAQ:GTXI)

4.81
Delayed Data
As of Jun 23
 +0.23 / +5.02%
Today’s Change
2.73
Today|||52-Week Range
11.19
-8.90%
Year-to-Date

Today’s Trading

Previous close4.58
Today’s open4.56
Day’s range4.42 - 4.89
Volume125,110
Average volume (3 months)157,918
Market cap$77.2M
Dividend yield--
Data as of 3:59pm ET, 06/23/2017

Growth & Valuation

Earnings growth (last year)+18.67%
Earnings growth (this year)+4.92%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book3.85

Competitors

 Today’s
change
Today’s
% change
CEMIChembio Diagnostics ...0.000.00%
SYNSynthetic Biologics ...-0.07-10.17%
NVETNexvet Biopharma plc0.000.00%
XENEXenon Pharmaceutical...+0.05+1.23%
Data as of 4:02pm ET, 06/23/2017

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$0.00
Annual profit (last year)-$17.7M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Marc Steven Hanover
Principal Financial &
Accounting Officer
Jason T. Shackelford
Corporate headquarters
Memphis, Tennessee

Forecasts